Sell Zoetis (ZTS) stock to fund a goal
Calculator · free · no signup · ZTSNeed cash for a goal? Plan the minimum-tax schedule to sell your vested Zoetis (ZTS) shares and net a target amount by a target date, across tax years.
AlphaLatitude Inc. · Free ToolsOur tools respect your browsing privacy. Independently verified:
Inputs
Your equity
One stack per ticker (current-employer RSUs, prior-employer holdings, index fund, etc.). Each stack has its own current price, growth assumption, and cost-basis lots.
Drives chance-of-shortfall · default 30%
Lots
Plan
Estimates only. Not financial advice.
Lock-in-now is deterministic (0%). Plans that wait depend on future prices; risk is near-zero when inventory comfortably exceeds the goal. Volatility: each stack's option-implied vol if a ticker is set, otherwise 30%. Lognormal model; real markets have fatter tails.
| Tax | $109,654 | $111,723 | $111,788 | $118,699 |
| Wealth @ target | $718,258 | $716,076 | $713,344 | $710,913 |
| Chance of shortfall | <0.1% | 0% | 1.7% | 3.3% |
Feasible
$400,027 net by 08/01/27
Total tax: $109,654 (federal $58,856, state $36,063, NIIT $14,736)
Schedule · Recommended
| Sale date | Shares | Tax | Net | Cumulative |
|---|---|---|---|---|
| 08/26/26 | 4,088 | $351,349 | $360,067 | |
| 03/31/27 | 4 | $359 | $360,430 | |
| 04/30/27 | 32 | $2,891 | $363,340 | |
| 05/31/27 | 100 | $9,088 | $372,468 | |
| 06/30/27 | 100 | $9,141 | $381,631 | |
| 07/31/27 | 100 | $9,196 | $390,828 | |
| 08/01/27 | 100 | $9,199 | $400,027 |
Risk vs wealth
Each dot is a possible plan. Right is riskier, up is more wealth left over.
Trajectory of cash netted
Solid line = expected. Shaded band = 10th–90th percentile under price uncertainty.
After the plan
You keep 3,476 shares worth $410,758 at the projected target-date price, invested for the next decision.
You solved for a cash target. The beta optimizes your full portfolio across multiple goals and market scenarios, not just one funding need.
Request beta access →Related calculators: RSU Lot Order Calculator · Stock Concentration Calculator · RSU Sell-vs-Hold Calculator
About Zoetis
Zoetis (ZTS) is a public Pharma/Biotech company, headquartered in Parsippany, NJ.
Last close: $69.69 per share (as of 2026-10-03).
Equity grants at Zoetis typically include restricted stock units (RSUs).
Zoetis Inc. (/zō-EH-tis/), headquartered in Parsippany, New Jersey, is the largest producer of medicine and vaccinations for pets and livestock worldwide. The company's products include antiparasitics, vaccines, products that relieve itch, anti-infectives, products that alleviate pain, animal health diagnostics, as well as hormones, cardiopulmonary, topical and oral hygiene therapeutics, central nervous system drugs, diuretics, antiemetic, euthanasia, and hepato-digestive products. The company has operations in over 50 countries.
Source: Wikipedia (CC BY-SA 4.0)
Pfizer separated its animal-health division in 2013, creating the largest company dedicated to medicines and vaccines for pets and livestock. The two halves behave differently: companion-animal products are bought by owners treating pets as family and support premium pricing, while livestock products are an input cost farmers optimize. Veterinary approvals are cheaper and faster than human drug approvals, which changes the economics of developing a product. Dermatology and pain treatments for dogs have been the growth franchise. Headquarters are in Parsippany, New Jersey.
Sources: sec.gov · en.wikipedia.org
Equity comp at Zoetis
- Zoetis uses double trigger change in control protection: unvested RSUs and stock options accelerate only if the equity holder is involuntarily terminated without cause, or resigns for good reason, within a defined window (up to 24 months) after a change in control. A change in control alone does not vest awards.
- RSUs use double-trigger vesting. Two things must both happen before the shares are yours: (1) the normal time-based vesting completes, and (2) the company has a liquidity event (an IPO or an acquisition). Until both happen, you do not yet own the shares and you do not owe tax on them.
Researched 2026-08-27.
OptionsAhoy is an independent tool and is not affiliated with, endorsed by, or sponsored by Zoetis.
If you hold vested Zoetis (ZTS) shares and need a set amount of cash by a date (a house down payment, tuition, a sabbatical, a business buy-in), the question is which lots to sell and in which tax years to keep the most after tax. This calculator builds the minimum-tax sell schedule across your lots, accounting for federal long-term capital gains, the net investment income tax, and your state.
Example: a 5,000-share ZTS position at $69.69 is worth $348,450. Say you need $150,000 of it for a house down payment by next spring. Selling enough shares all in one tax year can push the gain into the higher long-term capital-gains bracket and trigger the 3.8% net investment income tax; spreading the sale across two tax years often nets more. The calculator above finds the minimum-tax sell schedule across your specific lots, basis, goal, and date.
All Zoetis tools → · Use the generic Stock Sale Funding Calculator for any company.
Zoetis equity questions
- How much ZTS stock do I sell to fund a goal without overpaying tax?
- It depends on your cost basis, your target amount and date, and how the sale spreads across tax years. Selling vested ZTS shares triggers long-term capital-gains tax, plus the 3.8% net investment income tax and state tax above certain income, and bunching a large sale into one year can push the gain into a higher bracket. The calculator above builds the minimum-tax sell schedule across your lots to net your target amount by your date.
- Does Zoetis grant ISOs, NSOs, or RSUs?
- Equity compensation at Zoetis typically takes the form of restricted stock units (RSUs). Restricted stock units are taxed as ordinary income when they vest.
- Do Zoetis RSUs use double-trigger vesting?
- Yes. Zoetis restricted stock units (RSUs) vest only when two things both happen: the time-based schedule completes, and the company has a liquidity event such as an initial public offering (IPO) or an acquisition. Until both occur you do not own the shares and owe no tax on them.
Find another companyPharma/Biotech peers
One piece of the puzzle.
OptionsAhoy plans your Zoetis equity alongside hedging, vesting, and de-concentration, across bullish, neutral, and bearish market scenarios. Free during beta.